BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1391497)

  • 1. Lack of increased cardiac output during hemoglobin hemodilution can be reversed with sodium nitroprusside.
    Rooney MW; Hirsch LJ; Aasen MK; Goldberg SA; Mathru M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):689-92. PubMed ID: 1391497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodilution with oxyhemoglobin. Mechanism of oxygen delivery and its superaugmentation with a nitric oxide donor (sodium nitroprusside).
    Rooney MW; Hirsch LJ; Mathru M
    Anesthesiology; 1993 Jul; 79(1):60-72. PubMed ID: 8342830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart.
    Prendergast BD; Sagach VF; Shah AM
    Circulation; 1997 Aug; 96(4):1320-9. PubMed ID: 9286965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig.
    Herity NA; Allen JD; Silke B; Adgey AA
    Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit.
    Meisner FG; Kemming GI; Habler OP; Kleen MS; Tillmanns JH; Hutter JW; Bottino DA; Thein E; Meier JM; Wojtczyk CJ; Pape A; Messmer K
    Crit Care Med; 2001 Apr; 29(4):829-38. PubMed ID: 11373478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits.
    Caron A; Menu P; Faivre-Fiorina B; Labrude P; Alayash AI; Vigneron C
    J Appl Physiol (1985); 1999 Feb; 86(2):541-8. PubMed ID: 9931189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of systemic vasodilation during normovolemic hemodilution.
    Doss DN; Estafanous FG; Ferrario CM; Brum JM; Murray PA
    Anesth Analg; 1995 Jul; 81(1):30-4. PubMed ID: 7541185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs.
    Hobbhahn J; Vogel H; Kothe N; Brendel W; Peter K; Jesch F
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):537-43. PubMed ID: 4036540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium nitroprusside induced hypotension and isovolemic hemodilution in dogs.
    Boon JC; Jesch F; Stelter WJ; Messmer K
    Chir Forum Exp Klin Forsch; 1977 Apr; ():27-30. PubMed ID: 376243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
    Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
    Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasodilators on canine cardiopulmonary function when a decrease in cardiac output complicates an increase in right ventricular afterload.
    Ghignone M; Girling L; Prewitt RM
    Am Rev Respir Dis; 1985 Apr; 131(4):527-30. PubMed ID: 3994147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodilution does not alter the aortic-to-femoral arterial pressure difference in dogs.
    Urzua J; Nunez G; Lema G; Canessa R; Sacco C
    J Clin Monit Comput; 1999 Dec; 15(7-8):429-33. PubMed ID: 12578039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
    Bower EA; Law AC
    Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodilution does not alter arterial baroreflex control of heart rate in anesthetized dogs.
    Tanaka M; Nishikawa T
    Anesth Analg; 2003 Jan; 96(1):28-32, table of contents. PubMed ID: 12505918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental hypervolemic hemodilution: physiological correlations of cortical blood flow, cardiac output, and intracranial pressure with fresh blood viscosity and plasma volume.
    Wood JH; Simeone FA; Kron RE; Snyder LL
    Neurosurgery; 1984 Jun; 14(6):709-23. PubMed ID: 6462405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressure.
    Cabrales P; Tsai AG; Winslow RM; Intaglietta M
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2146-53. PubMed ID: 15637119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.